DNA sequencing in newborns reveals years of actionable findings for infants and families

Brigham and Women's Hospital |
June 2023
Press Release

“By screening apparently healthy newborns, entire families were alerted for the first time that dangerous but treatable genetic variants were present,” said corresponding author Robert C. Green, MD, MPH, a physician-scientist at Brigham and Women’s Hospital and professor of genetics at Harvard Medical School, who leads the BabySeq Project. “We were stunned to see that … Continued

The missing links: How to ensure omics data fulfills its promise

BioCentury |
May 2023
Press

“Omics data could herald a revolution in healthcare. The analysis of rich, interconnected and longitudinal multi-omics datasets promises a better understanding of the underlying biology of human health and disease, which in turn could lead to more effective prevention, earlier and more accurate diagnoses, new treatments and better choice of treatments. Despite that promise, only … Continued

2023 Newborn Screening Translational Research Network (NBSTRN) Network Meeting

On May 18-19, 2023 from 12-4pm (EST), the Newborn Screening Translational Research Network (NBSTRN) is hosting a two-day virtual meeting that will showcase the important role of advocacy and research in NBS. Robert Green, MD, MPH will lead a talk on the path to universal newborn sequencing. See the conference link below to learn more and … Continued

A meaningful and personal career transition

Brigham Clinical & Research News |
May 2023
G2P News

Shaye Williams, G2P’s operation coordinator and diversity, equity, and inclusion lead, shares the story of her career transition into genomics research. After being introduced to genetic counseling as a prenatal patient, Shaye pursued an internship with G2P to learn more about the profession.

Your DNA can now be pulled from thin air. Privacy experts are worried.

New York Times |
May 2023
Press

“Anna Lewis, a Harvard researcher who studies the ethical, legal and social implications of genetics research, said that environmental DNA hadn’t been widely discussed by experts in bioethics. But after the findings from Dr. Duffy and his colleagues, it will be.”

Genetics experts support adding hundreds of treatable rare diseases to newborn screening

National Center for Advancing Translational Sciences |
May 2023
Press

“In a newly released study, nearly nine of 10 experts on rare diseases agreed that sequencing healthy newborns’ DNA to reveal treatable genetic disorders should be available for all infants. At least half of experts also endorsed testing for more than 400 genes as part of such newborn genomic screens. These NCATS-supported study results might … Continued

Should all U.S. newborns undergo genomic testing?

U.S. News & World Report |
May 2023
Press

“While newborns are only screened for about 60 treatable conditions, there are hundreds of genetic disorders that have targeted treatments. Now, a national survey of experts in rare diseases found the vast majority support DNA sequencing in healthy newborns…’It has been a longstanding dream to someday offer DNA sequencing to all newborns in order to … Continued

Rare disease experts support newborn genome sequencing

Inside Precision Medicine |
May 2023
Press

“Research led by Mass General Hospital for Children suggests that almost 90% of rare disease experts are in favor of newborn genome sequencing for monogenic treatable disorders…’Early identification of infants who are at risk for genetic disorders can be lifesaving and screening has the potential to improve healthcare disparities for affected children,’ said lead author … Continued

Genetics Faculty Chalk Talk

Faculty in the Brigham and Women’s Hospital Division of Genetics share updates on their research in the Genetics Faculty Chalk Talk series.

Rare-disease doctors support expanded newborn genomic screening, survey finds

STAT |
May 2023
Press

“When 238 rare-disease doctors across the U.S. were surveyed by a research team at Mass General Brigham in Boston, 88% of them agreed that DNA sequencing to screen for certain treatable childhood disorders should be made available to all newborns. The study was published Monday in JAMA Network Open.”

Mass General Brigham-led study finds experts support DNA sequencing in newborns

Mass General Brigham |
May 2023
Press Release

“Findings from a new study led by researchers at Mass General Brigham suggest that rare disease experts are now in favor of more expansive newborn testing. In a study published today in JAMA Network Open, 88 percent of rare disease experts agreed that DNA sequencing to screen for treatable childhood disorders should be made available … Continued

Five questions with Nic Encina: Working upstream or downstream

Ariadne Labs |
April 2023
G2P News

“In our Five-Question series, we highlight the staff and faculty behind the compelling work at Ariadne Labs. Upstream or downstream? That has long been a career question for Nic Encina, MS, MS, MBA, now Director of Strategy of the Precision Population Health initiative at Ariadne Labs.”

G2P featured in Brigham Clinical & Research News “Look who’s talking”

Brigham Clinical & Research News |
April 2023
Press

Genomes2People was featured in the latest issue of Brigham Clinical & Research News “Look who’s talking”. Past winners of the Brigham Research Institute’s BRIght Futures Prize share about the impact that the $100,0000 award has had on their work and careers. “In 2012, we were delighted to be the very first winners of the BRIght … Continued

Frontiers in Pediatric Genomic Medicine Conference 2023

Robert C. Green, MD, MPH, will speak on a panel concerning newborn genomic screening programs across the globe at the 2023 Frontiers in Pediatric Genomic Medicine hybrid conference taking place in-person at Scripps Seaside Forum in La Jolla, CA and simultaneously streamed live.

G2P March Newsletter 2023

March 2023
G2P News

In this newsletter we’re excited to congratulate Sophia Adelson, Erin Drake, and Sheyenne Walmsley for winning the Brigham and Women’s Hospital Pillars of Excellence Awards. We’re also highlighting Carrie Zawatsky for her leadership in publishing NSGC’s first clinical practice resource on elective genetic testing, as well as Dr. Nina Gold’s NIH Mentored Clinical Scientist Research … Continued

Dr. Robert Green on the future of genetic testing

Beyond The Heart |
October 2022
Podcast

Robert C. Green, MD, MPH is Professor of Medicine (Genetics) at Harvard Medical School and a physician-scientist who directs the G2P Research Program at Brigham and Women’s Hospital, Broad Institute and Ariadne Labs. Dr. Green is internationally recognized for research and policy efforts accelerating the implementation of genomic/precision medicine. In this fascinating conversation Nieca and … Continued

The Lake Nona Impact Forum 2023 Event

Dr. Robert C. Green was invited to speak on the topic of Precision Medicine and Population Genomics on March 9th at the Lake Nona Impact Forum 2023 event. The three-day event took place in Lake Nona Medical City in Orlando, FL, a life sciences and healthcare cluster of excellence featuring some of the Nation’s top … Continued

2023 ACMG Annual Clinical Genetics Meeting

Robert C. Green, MD, MPH will be joined by David Bick, MD; Richard Scott, MD; Wendy K. Chung, MD and Stephen Kingsmore, MD, DSc presenting at the NBSeq Symposium during the first day of the conference. Close G2P Collaborator at Dartmouth Health Children’s, Nidhi D. Shah, MD, FACMG will present a poster on Perspectives of … Continued

G2P staff recognized for the Brigham Way

Brigham Awards, Honors & Grants |
January 2023
G2P News, Press

Congratulations to G2P Genetic Counselor Janelle Shea and Operations Coordinator Shaye Williams for being nominated for and winning The Brigham Way Award, which recognizes employees who foster a culture of excellence, respect and professionalism by going above and beyond their duties to create an exceptional Brigham Experience for our patients and colleagues. Janelle celebrated her … Continued